Related Experiment Video

Updated: Jun 24, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

Prognostic value of CA125 in advanced heart failure patients

Sílvia Monteiro, Fátima Franco, Susana Costa

    International Journal of Cardiology
    |March 17, 2009
    PubMed

    Insights

    In advanced heart failure (AHF), elevated CA125 levels predict a higher risk of death or heart transplant. This biomarker aids in better risk stratification for AHF patients.

    Area of Science:

    • Cardiology
    • Biomarker Research
    • Clinical Prognostics

    Background:

    • Serum CA125 levels are frequently elevated in patients with advanced heart failure (AHF).
    • Predicting adverse outcomes in AHF is crucial for patient management and resource allocation.

    Discussion:

    • Elevated CA125 in AHF correlates with poorer physiological parameters, including lower blood pressure, BMI, and exercise capacity, and higher B-type natriuretic peptide.
    • The study highlights the independent predictive value of CA125 and serum sodium for adverse events in AHF.

    Key Insights:

    • CA125 levels > or = 38 U/mL in AHF patients are associated with a significantly higher rate of death or cardiac transplantation.
    • Multivariate analysis identified CA125 as an independent predictor of mortality and transplantation in AHF.
    • CA125 serves as an effective prognostic marker for risk stratification in advanced heart failure.

    Outlook:

    • Further research could explore the mechanisms linking CA125 to heart failure progression.
    • Integrating CA125 into routine clinical assessment may improve prognostication and treatment strategies for AHF.
    • Investigating therapeutic interventions targeting pathways influenced by CA125 could offer new treatment avenues.
    Abstract

    Related Concept Videos

    Heart Failure IV: Classification and Diagnostic Evaluation01:30

    Heart Failure IV: Classification and Diagnostic Evaluation

    Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
    Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

    Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

    Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
    Pathophysiology of Heart Failure01:17

    Pathophysiology of Heart Failure

    Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    Heart Failure VII: Nursing Interventions01:30

    Heart Failure VII: Nursing Interventions

    The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
    Heart Failure VI: Adjunct Therapies01:22

    Heart Failure VI: Adjunct Therapies

    Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.